We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
BTK inhibition is a potent approach to block IgE-mediated histamine release in human basophils.
- Authors
Smiljkovic, D.; Blatt, K.; Stefanzl, G.; Dorofeeva, Y.; Skrabs, C.; Focke‐Tejkl, M.; Sperr, W. R.; Jaeger, U.; Valenta, R.; Valent, P.
- Abstract
Background Recent data suggest that Bruton's tyrosine kinase ( BTK) is an emerging therapeutic target in IgE receptor (Ig ER)-cross-linked basophils. Methods We examined the effects of four BTK inhibitors (ibrutinib, dasatinib, AVL-292, and CNX-774) on IgE-dependent activation and histamine release in blood basophils obtained from allergic patients (n=11) and nonallergic donors (n=5). In addition, we examined the effects of these drugs on the growth of the human basophil cell line KU812 and the human mast cell line HMC-1. Results All four BTK blockers were found to inhibit anti-IgE-induced histamine release from basophils in nonallergic subjects and allergen-induced histamine liberation from basophils in allergic donors. Drug effects on allergen-induced histamine release were dose dependent, with IC50 values ranging between 0.001 and 0.5 μmol/L, and the following rank order of potency: ibrutinib> AVL-292>dasatinib> CNX-774. The basophil-targeting effect of ibrutinib was confirmed by demonstrating that IgE-dependent histamine release in ex vivo blood basophils is largely suppressed in a leukemia patient treated with ibrutinib. Dasatinib and ibrutinib were also found to counteract anti-IgE-induced and allergen-induced upregulation of CD13, CD63, CD164, and CD203c on basophils, whereas AVL-292 and CNX-774 showed no significant effects. Whereas dasatinib and CNX-774 were found to inhibit the growth of HMC-1 cells and KU812 cells, no substantial effects were seen with ibrutinib or AVL-292. Conclusions BTK-targeting drugs are potent inhibitors of IgE-dependent histamine release in human basophils. The clinical value of BTK inhibition in the context of allergic diseases remains to be determined.
- Subjects
PROTEIN-tyrosine kinases; IMMUNOGLOBULIN E receptors; BASOPHILS; HISTAMINE; ALLERGIES; PATIENTS
- Publication
Allergy, 2017, Vol 72, Issue 11, p1666
- ISSN
0105-4538
- Publication type
Article
- DOI
10.1111/all.13166